Leap Therapeutics
LPTX
LPTX
22 hedge funds and large institutions have $3.86M invested in Leap Therapeutics in 2018 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
78% less capital invested
Capital invested by funds: $17.8M → $3.86M (-$13.9M)
Holders
22
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$77.8K | |
| 2 | +$72.6K | |
| 3 | +$58.7K | |
| 4 |
Renaissance Technologies
New York
|
+$48.1K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$32K |
Top Sellers
| 1 | -$2.59M | |
| 2 | -$403K | |
| 3 | -$236K | |
| 4 |
JPMorgan Chase & Co
New York
|
-$111K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$14K |